Sartorius Stedim Biotech SA (STU:56S1)
€ 193.8 -3.9 (-1.97%) Market Cap: 18.88 Bil Enterprise Value: 22.44 Bil PE Ratio: 57.41 PB Ratio: 6.74 GF Score: 91/100

Q2 2021 Sartorius AG and Sartorius Stedim Biotech SA Earnings Call Transcript

Jul 21, 2021 / 01:30PM GMT
Release Date Price: €435.1 (-3.05%)
Operator

Good day and welcome to the Sartorius and Sartorius Stedim Biotech conference call on the first half of 2021 results. Today's conference is being recorded.

At this time, I would like to turn the conference over to Dr. Joachim Kreuzburg, CEO. Please go ahead, sir.

Joachim Kreuzburg
Sartorius Aktiengesellschaft - Chairman of Executive Board & CEO

Thank you very much and good day, everybody, from Sartorius. I'm here together with Rainer Lehmann, our CFO, and we would like to talk about the half year's results of Sartorius and Sartorius Stedim Biotech as just announced.

As always, I would like to kick it off with mentioning a couple of highlights that we see being the most important developments during the first 6 months of this year, then Rainer will talk -- take over and talk about the financial results in more detail and then I will continue with the outlook for the full year and the SSB results.

So we have been achieving 60% top line growth during the first 6 months. Of this, 22 percentage points are corona-related. We will

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot